Therapeutics Acquisition Corp.
RACA
$10.27
Updated: 23/09/2026, 13:03:05
Market Cap
$1.09B
Sector
Financial Services
Industry
Shell Companies
Country
US
No historical data available
Company Profile
Therapeutics Acquisition Corp., which operates as Research Alliance Corp. I, was founded in 2020 and is headquartered in Boston, Massachusetts. Its core mission is to pursue a business combination, including but not limited to mergers, capital stock exchanges, asset acquisitions, share purchases, or reorganizations, with one or more enterprises in the United States healthcare sector.
USD
NASDAQ
CEO: Peter Kolchinsky
Asset Summaries
Latest generated summaries for RACA
No summaries found.
Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for RACA.
- Share price
- $10.27
- Market cap
- $1.09B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Peter Kolchinsky
- Employees
- N/A
- IPO date
- 07/08/2020
- Beta
- 0
- Last dividend
- $0.00
- Day range
- $10.00 – $10.33
- 52-week range
- $9.81 – $18.08
- 1-day performance
- 2.44%
- 1-year performance
- 4.73%
- Current drawdown (1Y)
- -43.17%
- CIK
- 0001811764
- CUSIP
- N/A
- ISIN
- N/A
- Created
- 07/12/2025, 13:55:04
- Last update
- 23/09/2026, 13:03:05
Track Therapeutics Acquisition Corp. with an AI analyst
See which prediction-market events move RACA, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Latest Database News
News linked to RACA from your Railway `news_articles` table.
No news found for this symbol.